Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Clinical trial NCT00394745 · COMPLETED

Trial details

NCT number: NCT00394745
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension Metabolic Syndrome

Start date: 2005-11-01
Primary completion: 2007-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.